MedTrace Logo

Experiences of Brief Admission From the Perspective of Family and Significant Others

NCT04962217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2024-01-31

No results posted yet for this study

Summary

As a result of a randomized controlled trial (NCT02985047) BA is continuously offered to persons with self-harm at risk for suicide in Skåne, Sweden. This qualitative inductive study aims to provide experiences among family members, carers and significant others of Brief Admission by self-referral for self-harming and suicidal persons based on individual semi-structured interviews. Participants will be identified through suggestion from persons with an active BA contract. Interviews, estimated to last 30-60 minutes, will be analyzed by a phenomenological hermeneutic method or by content analysis depending on richness and depth in the interviews. Findings from this study will be published.

Conditions

  • Suicidal Ideation
  • Self Injurious Behavior Without Suicidal Intent
  • Self-Harm, Deliberate

Interventions

OTHER

Semi-structured interviews

Each participant will attend a 30-60 minute semi-structured interview conducted by the CI

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Region Skane

    lead OTHER

Principal Investigators

  • Sofie Westling, PhD · Region Skåne

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04962217 on ClinicalTrials.gov